Valuation : Sanofi

Market Cap 92.08B 107B 86.62B 78.91B 148B 10,131B 149B 1,024B 399B 5,154B 401B 392B 17,088B P/E 2026 *
12.3x
P/E 2027 * 10.7x
Enterprise Value 104B 120B 97.4B 88.73B 167B 11,392B 168B 1,151B 448B 5,795B 451B 441B 19,215B EV / Sales 2026 *
2.17x
EV / Sales 2027 * 1.98x
Free-Float
88.34%
Yield 2026 *
5.54%
Yield 2027 * 5.85%
1 day+0.25%
1 week-1.66%
Current month+0.04%
1 month+3.40%
3 months+4.48%
6 months-5.63%
Current year-7.30%
1 week 76.83
Extreme 76.83
78.11
1 month 73.85
Extreme 73.85
79.09
Current year 71.72
Extreme 71.72
85.4
1 year 71.72
Extreme 71.72
90.46
3 years 71.72
Extreme 71.72
110.02
5 years 71.72
Extreme 71.72
110.02
10 years 63.1
Extreme 63.1
110.02
Manager TitleAgeSince
Chief Executive Officer 65 2026-04-30
Director of Finance/CFO 64 2024-03-31
Chief Tech/Sci/R&D Officer 51 2023-09-10
Director TitleAgeSince
Director/Board Member 61 2019-04-29
Director/Board Member 57 2020-04-27
Director/Board Member 65 2020-04-27
Change 5-day change 1-year change 3-year change Capi.($)
+0.26%-1.66% - - 107B
+0.28%-5.97%+58.34%+108.22% 1,034B
+2.01%-0.71%+53.07%+68.99% 654B
+1.39%-2.18%+23.57%+75.43% 459B
+1.12%-4.75%+33.89%+36.15% 343B
-0.18%+2.61%+28.95%+46.58% 307B
+0.28%-2.11%+0.60%+12.03% 251B
+1.92%-0.93%+52.28%+70.67% 237B
+0.57%-3.23%-17.67%-54.97% 202B
+2.45%+0.77%+32.71%+95.59% 186B
Average +0.88%-2.88%+29.53%+50.96% 407.95B
Weighted average by Cap. +0.74%-3.31%+38.51%+66.66%

Financials

2026 *2027 *
Net sales 47.68B 55.28B 44.85B 40.86B 76.84B 5,246B 77.26B 530B 206B 2,669B 208B 203B 8,849B 50.81B 58.9B 47.79B 43.54B 81.88B 5,590B 82.32B 565B 220B 2,844B 221B 216B 9,429B
Net income 7.91B 9.17B 7.44B 6.78B 12.75B 870B 12.82B 87.97B 34.24B 443B 34.43B 33.69B 1,468B 9.24B 10.72B 8.7B 7.92B 14.9B 1,017B 14.98B 103B 40.01B 517B 40.23B 39.36B 1,715B
Net Debt 11.46B 13.28B 10.78B 9.82B 18.46B 1,261B 18.56B 127B 49.59B 641B 49.87B 48.79B 2,126B 8.3B 9.63B 7.81B 7.12B 13.38B 914B 13.45B 92.34B 35.94B 465B 36.14B 35.36B 1,541B
Logo Sanofi
Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows: - pharmaceutical products (81.8%): prescription drugs for the treatment of multiple sclerosis, neurological diseases, inflammatory diseases, autoimmune diseases, rare diseases, cancers and rare hematological diseases; - human vaccines (18.2%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas. At the end of 2025, the group had 37 production sites worldwide. Net sales are distributed geographically as follows: France (3.9%), Europe (17.1%), the United States (50.8%), China (6%) and other (22.2%).
Employees
74,846
Date Price Change Volume
26-09-02 76.96 +0.05% 34
26-09-01 €76.92 -0.01% 2,480
26-08-31 €76.93 -0.59% 1,212
26-08-28 €77.39 +0.57% 1,962
26-08-27 €76.95 -1.67% 1,278
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
76.86EUR
Average target price
94.28EUR
Spread / Average Target
+22.66%

Quarterly revenue - Rate of surprise